Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: greedsgd_2000 who wrote (3886)	5/28/2001 11:40:05 AM
From: Spekulatius	Read Replies (1) \| Respond to of 52153

>> CLASSIC EXAMPLE OF A SHORT CORRUPTING HER ANALYSIS << I think that this is actually one of the better articles from the street.com. Biotech's indeed have had a wonderful run and many stocks are up 50-100% from their lows in April. While many Biotechs have been undervalued then ,most appear fairly well valued right now. In addition, Biotech stocks are mostly liquidity driven short term, so if liquidity shrinks, the stocks will have to go down.